OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

Vulvar Cancer Staging

FIGO Vulvar Staging (2021)

Updated Nodes Classification

I

Confined to Vulva/Perineum

IA (≤2cm, ≤1mm invasion) | IB (>2cm or >1mm invasion)

II

Adjacent Tissue Extension

Lower 1/3 Urethra, Vagina, or Anus (Nodes Negative)

III

Positive Regional Nodes

IIIA (1 node ≥5mm or 1–2 nodes <5mm) | IIIB (2+ nodes ≥5mm) | IIIC (Extracapsular spread)

IV

Upper Tract / Distant

IVA (Upper 2/3 Urethra/Vagina, Bladder/Rectum mucosa) | IVB (Distant Metastasis)

The 2021 update refined the Prognostic Node groups (Stage III) based on absolute node size and extracapsular spread.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Primary Clinical Uses

Surgical/pathological staging of primary vulvar squamus cell carcinoma and melanomas
Major determinant for the extent of inguinofemoral lymph node dissection
Guiding the necessity for adjuvant groin/pelvic radiotherapy

The 2021 Update

The 2021 FIGO update made critical modifications regarding lymph node morphology. Extracapsular spread (ECS) in the groin nodes is now officially recognized as overwhelmingly prognostic and immediately upstages the patient to IIIC.
Section 2

Formula & Logic

Stage I — Confined to Vulva/Perineum (No Nodal Spread)

IATumor ≤ 2 cm AND stromal invasion ≤ 1 mm
IBTumor > 2 cm OR stromal invasion > 1 mm

Stage II — Local Adjacent Spread (No Nodal Spread)

IIExtension to lower 1/3 of urethra, lower 1/3 of vagina, or anus

Stage III — Inguinofemoral Lymph Nodes

IIIA1 or 2 lymph nodes with metastasis < 5 mm AND no extracapsular spread
IIIB≥ 3 nodes (< 5mm) OR ≥ 1 node (≥ 5 mm) AND no extracapsular spread
IIICANY lymph node metastasis with Extracapsular Spread (ECS)

Stage IV — Deep Regional or Distant Spread

IVAUpper 2/3 urethra/vagina, bladder/rectal mucosa, fixed to pelvic bone, or fixed/ulcerated nodes
IVBDistant metastasis, including pelvic lymph nodes
Section 3

Pearls/Pitfalls

Nodal Nuances

Groin node status is the single most important prognostic factor for overall survival.
Note that pelvic lymph node involvement (iliac/obturator) bypasses Stage III completely and is classified as Stage IVB (distant metastasis).
Stage IA patients have an essentially zero risk of nodal metastases. They strictly require wide local excision only and should be spared the severe morbidity of groin dissection.
Section 4

Next Steps

Surgical Management Guidelines

01
Stage IA: Wide local excision (WLE). Observation of groins.
02
Stage IB / II (Lateral tumor, >2cm from midline): WLE + ipsilateral inguinofemoral lymph node evaluation (or Sentinel Lymph Node biopsy).
03
Stage IB / II (Central tumor, <2cm from midline): WLE + bilateral inguinofemoral lymph node evaluation.
04
Positive Sentinel Node or ECS: Proceed to full genitofemoral lymphadenectomy and immediate planning for adjuvant groin/pelvic radiotherapy.
Section 5

Evidence Appraisal

Current Guidelines

FIGO staging for carcinoma of the vulva: 2021 revision.

Olawaiye AB et al. • Int J Gynaecol Obstet.. 2021;Formalized the devastating prognostic impact of extracapsular spread by moving it to its own category (IIIC) and restructured tumor invasion depth metrics.

Section 6

Literature

Historical Context

Prior to the 1990s, vulvar cancer was uniformly treated by the brutal "en bloc" radical vulvectomy with bilateral groin dissections. Modern staging allows for highly targeted, tissue-sparing surgery to prevent catastrophic lymphedema while maintaining survival rates.

Last Comprehensive Review: 2026

Related Obstetrics Tools

APGAR Score
Assisted Delivery
Bishop Score
BPP
CARPREG II Cardiac Risk
Cervical Cancer Staging
Contraceptive Pearl Index
Doppler Matrix
EFW
Endometrial Staging
Have feedback about this calculator?Let us know.